| Follicular Lymphoma investigated in trials for …INVESTIGATED_IN_TRIALSderived15 of 110show all (up to 200) |
|---|
| → investigated in trials for | Rituximabmonoclonal_antibody 165 trials (42 active) · roll-up of the cancer and its descendants | — | — | Follicular Lymphoma | 165 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Cyclophosphamidesmall molecule 90 trials (36 active) · roll-up of the cancer and its descendants | — | — | Follicular Lymphoma | 90 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Fludarabinesmall molecule 70 trials (19 active) · roll-up of the cancer and its descendants | — | — | Follicular Lymphoma | 70 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Lenalidomidesmall_molecule 58 trials (30 active) · roll-up of the cancer and its descendants | — | — | Follicular Lymphoma | 58 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Obinutuzumabmonoclonal_antibody 41 trials (17 active) · roll-up of the cancer and its descendants | — | — | Follicular Lymphoma | 41 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Bendamustinesmall molecule 40 trials (18 active) · roll-up of the cancer and its descendants | — | — | Follicular Lymphoma | 40 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Vincristinesmall molecule 36 trials (16 active) · roll-up of the cancer and its descendants | — | — | Follicular Lymphoma | 36 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Doxorubicinsmall molecule 29 trials (17 active) · roll-up of the cancer and its descendants | — | — | Follicular Lymphoma | 29 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Prednisonesmall molecule 28 trials (14 active) · roll-up of the cancer and its descendants | — | — | Follicular Lymphoma | 28 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Ibrutinibsmall molecule 25 trials (8 active) · roll-up of the cancer and its descendants | — | — | Follicular Lymphoma | 25 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Bortezomibsmall molecule 24 trials (0 active) · roll-up of the cancer and its descendants | — | — | Follicular Lymphoma | 24 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Etoposidesmall molecule 20 trials (4 active) · roll-up of the cancer and its descendants | — | — | Follicular Lymphoma | 20 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Mosunetuzumabmonoclonal_antibody 20 trials (19 active) · roll-up of the cancer and its descendants | — | — | Follicular Lymphoma | 20 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Epcoritamabmonoclonal_antibody 18 trials (15 active) · roll-up of the cancer and its descendants | — | — | Follicular Lymphoma | 18 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Pembrolizumabmonoclonal antibody 17 trials (5 active) · roll-up of the cancer and its descendants | — | — | Follicular Lymphoma | 17 | Observed | clinicaltrials | graph → |